Onychomycosis Global Market Report 2025

Description

Onychomycosis is a fungal infection that affects the nail matrix, bed, or plate, impacting both toenails and fingernails. This condition can result in discoloration, thickening, and crumbling of the nails. The primary goal of treatment is to eliminate the infection, restore the health and appearance of the nails, and prevent the fungus from spreading to other nails or the surrounding skin.

The primary types of onychomycoses include distal subungual onychomycosis (DSO), white superficial onychomycosis (WSO), proximal subungual onychomycosis (PSO), candida onychomycosis, and others. Distal subungual onychomycosis (DSO) specifically targets the nails of the feet, and treatment options vary, encompassing oral antifungal drugs, topical antifungal treatments, or a combination of both. The therapeutic approaches involve drug treatment, topical therapy, and other interventions, with distribution channels including hospital pharmacies, retail pharmacies, and other relevant outlets.

The onychomycosis research report is one of a series of new reports from The Business Research Company that provides onychomycosis market statistics, including the onychomycosis industry's global market size, regional shares, competitors with onychomycosis market share, detailed onychomycosis market segments, market trends and opportunities, and any further data you may need to thrive in the onychomycosis industry. This onychomycosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The onychomycosis market size has grown strongly in recent years. It will grow from $3.63 billion in 2024 to $3.83 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to limited treatment options, an aging population, increased incidence of diabetes, expansion of the pharmaceutical industry, and growing awareness of fungal infections

The onychomycosis market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to the adoption of combination drug therapies, increasing healthcare expenditure, growing awareness campaigns for onychomycosis, expansion of telemedicine services, and advances in topical drug formulations. Major trends in the forecast period include the integration of digital technologies in onychomycosis diagnosis and management, rise in over-the-counter (OTC) antifungal products, development of patient-friendly treatment regimens, emphasis on personalized medicine in onychomycosis treatment, collaboration between pharmaceutical companies for research and development.

The increasing prevalence of diabetes is anticipated to drive the growth of the onychomycosis market in the future. Diabetes is a chronic condition characterized by either inadequate insulin production by the pancreas or the body's inability to effectively use insulin. Individuals with diabetes are particularly susceptible to onychomycosis, a common foot issue, and managing complications associated with this infection is crucial for their health. Consequently, the rising incidence of diabetes is boosting demand in the onychomycosis market. For example, in June 2024, the National Health Service (NHS), a UK government agency, reported that in 2023, over half a million (549,000) more individuals in England were identified as at risk of developing type 2 diabetes. This increased the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330, reflecting a significant rise from 3,065,825 in 2022, or nearly 20%. Therefore, the growing incidence of diabetes is fueling the expansion of the onychomycosis market.

The globalization of pharmaceutical companies is poised to contribute to the expansion of the onychomycosis market. This trend involves pharmaceutical companies extending their operations beyond domestic or local markets to operate on a global scale. Global pharmaceutical companies play a vital role in conducting awareness campaigns and educational initiatives on various health conditions, including onychomycosis. Such initiatives contribute to increased awareness among healthcare professionals and the general public regarding the condition's prevalence and available treatment options. As an example, data from Germany Trade and Invest, a Germany-based office for foreign trade, reveals that Germany, being the fourth-largest pharmaceutical market globally and the largest in Europe, experienced a 5.4% increase in pharmaceutical sales to reach EUR 56.5 billion in 2022. The growth in biologics was particularly notable, reaching 10.5% between 2021 and 2022, generating EUR 17.8 billion in revenue in 2022 and constituting one-third of the country's entire pharmaceutical business. The globalization of pharmaceutical companies is thus playing a significant role in driving the growth of the onychomycosis market.

Product innovation is a significant trend gaining traction in the onychomycosis market. Leading companies in this sector are developing novel products to maintain their competitive edge. For example, in January 2024, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical firm, announced that the Food and Drug Administration (FDA) approved VTR-297 for the treatment of onychomycosis. VTR-297 is a small molecule histone deacetylase (HDAC) inhibitor that demonstrates antifungal activity specifically against dermatophytes and other fungi. This mechanism is essential for effectively targeting the pathogens responsible for onychomycosis. The drug is intended for topical application, enabling direct application to the affected nails. This localized delivery system reduces systemic exposure and minimizes potential side effects linked to oral antifungal treatments.

Key players in the onychomycosis market are also developing innovative formulations to strengthen their market position. These formulations enhance treatment outcomes and address specific challenges related to the condition. For instance, in February 2024, Moberg Pharma AB, a Sweden-based pharmaceutical company, launched MOB-015, a proprietary topical formulation of terbinafine aimed at delivering effective concentrations directly to the nail and nail bed while reducing the risk of systemic exposure linked to oral terbinafine. The product has received recommendations for national approval in 13 European countries and is marketed in Sweden under the brand name Terclara. The approval is supported by two Phase 3 trials demonstrating that MOB-015 achieved superior mycological cure rates (76% compared to up to 42% for comparators) and a significantly higher complete cure rate, with no serious adverse reactions reported.

In July 2023, Cipher Pharmaceuticals Inc., a Canadian pharmaceutical company, formed a partnership with Moberg Pharma to commercialize MOB-015, a topical nail fungus treatment known for its superior clinical cure rates. Moberg Pharma secured EU approval and intends to launch the product across 13 European countries. Moberg Pharma AB is a Sweden-based pharmaceutical firm that specializes in treatments for onychomycosis.

Major companies operating in the onychomycosis market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr.Reddy's Laboratories Ltd., Apotex Inc, Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., Zydus Cadila Healthcare Limited.

North America was the largest region in the onychomycosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the onychomycosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The onychomycosis market includes revenues earned by services such as combination therapy, oral antifungal medications, itraconazole, ketoconazole, griseofulvin, and terbinafine. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Onychomycosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on onychomycosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for onychomycosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The onychomycosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Distal Subungual Onychomycosis (DSO); White Superficial Onychomycosis (WSO); Proximal Subungual Onychomycosis (PSO); Candida Onychomycosis; Other Types
2) By Treatment: Drug Treatment; Topical Therapy; Other Treatments
3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Distal Subungual Onychomycosis (DSO): Dermatophyte Infections; Mixed Infections
2) By White Superficial Onychomycosis (WSO): Trichophyton Mentagrophytes Infections; Other Non-Dermatophyte Infections
3) By Proximal Subungual Onychomycosis (PSO): Associated with Nail Psoriasis; Fungal Infections In Immunocompromised Patients
4) By Candida Onychomycosis: Candidal Nail Infections; Mixed Fungal-Candida Infections
5) By Other Types: Total Nail Dystrophy; Secondary Onychomycosis
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25167

1. Executive Summary

2. Onychomycosis Market Characteristics

3. Onychomycosis Market Trends And Strategies

4. Onychomycosis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Onychomycosis Growth Analysis And Strategic Analysis Framework

5.1. Global Onychomycosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Onychomycosis Market Growth Rate Analysis
5.4. Global Onychomycosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Onychomycosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Onychomycosis Total Addressable Market (TAM)

6. Onychomycosis Market Segmentation

6.1. Global Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Distal Subungual Onychomycosis (DSO)
White Superficial Onychomycosis (WSO)
Proximal Subungual Onychomycosis (PSO)
Candida Onychomycosis
6.2. Global Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Treatment
Topical Therapy
Other Treatments
6.3. Global Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals Pharmacies
Retail Pharmacies
Other Distribution Channels
6.4. Global Onychomycosis Market, Sub-Segmentation Of Distal Subungual Onychomycosis (DSO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dermatophyte Infections
Mixed Infections
6.5. Global Onychomycosis Market, Sub-Segmentation Of White Superficial Onychomycosis (WSO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trichophyton Mentagrophytes Infections
Other Non-Dermatophyte Infections
6.6. Global Onychomycosis Market, Sub-Segmentation Of Proximal Subungual Onychomycosis (PSO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Associated with Nail Psoriasis
Fungal Infections In Immunocompromised Patients
6.7. Global Onychomycosis Market, Sub-Segmentation Of Candida Onychomycosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Candidal Nail Infections
Mixed Fungal-Candida Infections
6.8. Global Onychomycosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Total Nail Dystrophy
Secondary Onychomycosis

7. Onychomycosis Market Regional And Country Analysis

7.1. Global Onychomycosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Onychomycosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Onychomycosis Market

8.1. Asia-Pacific Onychomycosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Onychomycosis Market

9.1. China Onychomycosis Market Overview
9.2. China Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Onychomycosis Market

10.1. India Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Onychomycosis Market

11.1. Japan Onychomycosis Market Overview
11.2. Japan Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Onychomycosis Market

12.1. Australia Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Onychomycosis Market

13.1. Indonesia Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Onychomycosis Market

14.1. South Korea Onychomycosis Market Overview
14.2. South Korea Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Onychomycosis Market

15.1. Western Europe Onychomycosis Market Overview
15.2. Western Europe Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Onychomycosis Market

16.1. UK Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Onychomycosis Market

17.1. Germany Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Onychomycosis Market

18.1. France Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Onychomycosis Market

19.1. Italy Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Onychomycosis Market

20.1. Spain Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Onychomycosis Market

21.1. Eastern Europe Onychomycosis Market Overview
21.2. Eastern Europe Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Onychomycosis Market

22.1. Russia Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Onychomycosis Market

23.1. North America Onychomycosis Market Overview
23.2. North America Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Onychomycosis Market

24.1. USA Onychomycosis Market Overview
24.2. USA Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Onychomycosis Market

25.1. Canada Onychomycosis Market Overview
25.2. Canada Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Onychomycosis Market

26.1. South America Onychomycosis Market Overview
26.2. South America Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Onychomycosis Market

27.1. Brazil Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Onychomycosis Market

28.1. Middle East Onychomycosis Market Overview
28.2. Middle East Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Onychomycosis Market

29.1. Africa Onychomycosis Market Overview
29.2. Africa Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Onychomycosis Market Competitive Landscape And Company Profiles

30.1. Onychomycosis Market Competitive Landscape
30.2. Onychomycosis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Onychomycosis Market Other Major And Innovative Companies

31.1. Sandoz International GmbH
31.2. Bausch Health Companies Inc.
31.3. Perrigo Company plc
31.4. Galderma Laboratories LP
31.5. Aurobindo Pharma Limited
31.6. Cipla Inc.
31.7. Dr.Reddy's Laboratories Ltd.
31.8. Apotex Inc
31.9. Lupin Limited
31.10. Amneal Pharmaceuticals Inc.
31.11. Alembic Pharmaceuticals Inc.
31.12. Kaken Pharmaceutical Co. Ltd.
31.13. Mayne Pharma Group Limited
31.14. Wockhardt Ltd.
31.15. Jubilant Cadista Pharmaceuticals Inc.

32. Global Onychomycosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Onychomycosis Market

34. Recent Developments In The Onychomycosis Market

35. Onychomycosis Market High Potential Countries, Segments and Strategies

35.1 Onychomycosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Onychomycosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Onychomycosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer